Secai Marche
Series A in 2024
Secai Marche is a platform that connects farmers, chefs, and consumers to source and deliver farm-direct ingredients. It enables restaurants to purchase high-quality products directly from farmers, offering end-to-end services such as sourcing, order processing, payment, and delivery. Through its Secai Marche and sanchoku offerings, the platform delivers seasonal, regionally sourced ingredients while helping small-scale farms access markets and achieve profitable sales. Founded in 2018 and based in Tokyo with an additional location in Kuala Lumpur, the company operates globally to promote economically viable, sustainable farming. By simplifying procurement and logistics, the platform supports farmers’ livelihoods and strengthens local supply chains for restaurants seeking fresh, traceable ingredients.
Sakana Dream
Seed Round in 2023
Sakana Dream is a Japanese company specializing in aquaculture innovation. It employs a unique breeding technology called Surrogate Broodstock Technology to select and breed exceptional fish from over 4,000 species found in Japan. The company's focus is on creating hybrid fish that combine excellent taste with high productivity, aiming to contribute to sustainable and eco-friendly fish farming practices.
Olive Union
Venture Round in 2023
Olive Union Inc. is a company that focuses on developing innovative hearing aids aimed at improving the experience of individuals with hearing impairments. Founded in 2016 and headquartered in Tokyo, Japan, Olive Union utilizes advanced sound algorithms to create next-generation hearing solutions that integrate seamlessly with everyday technology. Their flagship device features a hearing process engine capable of making and receiving calls, as well as streaming music. Additionally, the device connects to a smartphone application for conducting hearing tests, which automatically adjusts audio frequencies to optimize sound quality while minimizing background noise. By addressing the common challenges of high costs and social stigma associated with traditional hearing aids, Olive Union aims to provide users with an accessible and effective solution for enhanced auditory experiences.
BiPSEE
Venture Round in 2023
BiPSEE is a medical XR company based in Tokyo, Japan, specializing in innovative treatment support for children. The company utilizes augmented reality (AR) and virtual reality (VR) technologies to alleviate anxiety and pain in various medical settings, including dentistry, pediatrics, and dermatology. By integrating one-button solutions for dental and medical procedures, BiPSEE aims to enhance the overall experience for young patients, fostering a sense of self-efficacy and improving their mental well-being. Additionally, BiPSEE offers a third-generation cognitive-behavioral therapy that provides immersive environments designed to help users gain new perspectives on their mental health, thereby promoting overall wellness.
Secai Marche
Series A in 2023
Secai Marche is a platform that connects farmers, chefs, and consumers to source and deliver farm-direct ingredients. It enables restaurants to purchase high-quality products directly from farmers, offering end-to-end services such as sourcing, order processing, payment, and delivery. Through its Secai Marche and sanchoku offerings, the platform delivers seasonal, regionally sourced ingredients while helping small-scale farms access markets and achieve profitable sales. Founded in 2018 and based in Tokyo with an additional location in Kuala Lumpur, the company operates globally to promote economically viable, sustainable farming. By simplifying procurement and logistics, the platform supports farmers’ livelihoods and strengthens local supply chains for restaurants seeking fresh, traceable ingredients.
The Ethical Spirits
Venture Round in 2022
Ethical Spirits is a craft gin brand that focuses on sustainability by transforming sake lees from Kuramae, Tokyo, and surplus beer into premium gin. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. Ethical Spirits offers a subscription service, allowing consumers to enjoy a variety of flavored drinks on a monthly basis. Through its innovative approach, the company aspires to establish itself as a lasting brand in the spirits market while promoting ethical consumption practices.
Grand Green
Series B in 2022
Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.
Integriculture
Series A in 2022
Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.
Koala Tech
Venture Round in 2021
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
The Ethical Spirits
Seed Round in 2021
Ethical Spirits is a craft gin brand that focuses on sustainability by transforming sake lees from Kuramae, Tokyo, and surplus beer into premium gin. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. Ethical Spirits offers a subscription service, allowing consumers to enjoy a variety of flavored drinks on a monthly basis. Through its innovative approach, the company aspires to establish itself as a lasting brand in the spirits market while promoting ethical consumption practices.
Secai Marche
Seed Round in 2021
Secai Marche is a platform that connects farmers, chefs, and consumers to source and deliver farm-direct ingredients. It enables restaurants to purchase high-quality products directly from farmers, offering end-to-end services such as sourcing, order processing, payment, and delivery. Through its Secai Marche and sanchoku offerings, the platform delivers seasonal, regionally sourced ingredients while helping small-scale farms access markets and achieve profitable sales. Founded in 2018 and based in Tokyo with an additional location in Kuala Lumpur, the company operates globally to promote economically viable, sustainable farming. By simplifying procurement and logistics, the platform supports farmers’ livelihoods and strengthens local supply chains for restaurants seeking fresh, traceable ingredients.
Libero Thera
Venture Round in 2021
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
Olive Union
Series B in 2021
Olive Union Inc. is a company that focuses on developing innovative hearing aids aimed at improving the experience of individuals with hearing impairments. Founded in 2016 and headquartered in Tokyo, Japan, Olive Union utilizes advanced sound algorithms to create next-generation hearing solutions that integrate seamlessly with everyday technology. Their flagship device features a hearing process engine capable of making and receiving calls, as well as streaming music. Additionally, the device connects to a smartphone application for conducting hearing tests, which automatically adjusts audio frequencies to optimize sound quality while minimizing background noise. By addressing the common challenges of high costs and social stigma associated with traditional hearing aids, Olive Union aims to provide users with an accessible and effective solution for enhanced auditory experiences.
Gojo & Company
Series D in 2020
Founded in 2014, Gojo & Company is a Tokyo-based holding company that enables financial inclusion for underserved communities worldwide. It invests in and partners with microfinance institutions across Southeast Asia, South Asia, Central Asia, the Caucasus, and Africa, aiming to provide access to financial services regardless of one's background.
Anaut develops artificial intelligence–based software for surgical support. Its platform analyzes complex internal information in real time during procedures, assisting surgeons with image analysis and recognition of body structures. By continuously training on a large set of surgical videos, the system improves accuracy, expands detectable anatomy, and enables cross‑sectional analysis of thoracic, abdominal, and pelvic surgeries. The technology enhances intraoperative visualization, supports decision‑making, and helps manage potential complications.
Regional Fish
Series A in 2020
Regional Fish is a Kyoto, Japan–based food tech company founded in 2019 that develops high-speed breeding technologies for fish. It produces and sells seeds and seedlings based on genome technology and works on genome-edited food, aiming to enable sustainable land-based aquaculture of valuable species. The company leverages AI-driven methods to accelerate breeding and enhance efficiency in the fisheries sector, pursuing an eco-system with a low environmental footprint through clean energy use and the management of waste organic nitrogen. By combining genome editing with smart aquaculture practices, Regional Fish seeks to advance innovations in the aquatic industry while reducing environmental impact.
Regional Fish
Seed Round in 2020
Regional Fish is a Kyoto, Japan–based food tech company founded in 2019 that develops high-speed breeding technologies for fish. It produces and sells seeds and seedlings based on genome technology and works on genome-edited food, aiming to enable sustainable land-based aquaculture of valuable species. The company leverages AI-driven methods to accelerate breeding and enhance efficiency in the fisheries sector, pursuing an eco-system with a low environmental footprint through clean energy use and the management of waste organic nitrogen. By combining genome editing with smart aquaculture practices, Regional Fish seeks to advance innovations in the aquatic industry while reducing environmental impact.
MabGenesis
Series A in 2020
Founded in 2019, MabGenesis is a biopharmaceutical company based in Yokohama, Japan. It specializes in developing therapeutic monoclonal antibody drugs for both human and animal use.
Integriculture
Series A in 2020
Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.
MabGenesis
Seed Round in 2020
Founded in 2019, MabGenesis is a biopharmaceutical company based in Yokohama, Japan. It specializes in developing therapeutic monoclonal antibody drugs for both human and animal use.
Grand Green
Series A in 2020
Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.
Koala Tech
Venture Round in 2020
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
Secai Marche
Seed Round in 2019
Secai Marche is a platform that connects farmers, chefs, and consumers to source and deliver farm-direct ingredients. It enables restaurants to purchase high-quality products directly from farmers, offering end-to-end services such as sourcing, order processing, payment, and delivery. Through its Secai Marche and sanchoku offerings, the platform delivers seasonal, regionally sourced ingredients while helping small-scale farms access markets and achieve profitable sales. Founded in 2018 and based in Tokyo with an additional location in Kuala Lumpur, the company operates globally to promote economically viable, sustainable farming. By simplifying procurement and logistics, the platform supports farmers’ livelihoods and strengthens local supply chains for restaurants seeking fresh, traceable ingredients.
Sonoligo
Venture Round in 2019
Sonoligo Inc. is an internet-based company founded in 2018 and headquartered in Kariya, Japan. It operates an online platform that offers access to a variety of cultural events, including music, sports, and art, through a monthly subscription model. The platform enables users to participate in real events, engage with online experiences, and view video content tailored to diverse interests and age groups. By providing a flat rate service, Sonoligo aims to make cultural experiences accessible to a wide audience.
Vitaars
Venture Round in 2019
Vitaars, known as T-ICU Co., Ltd., is a Japanese company headquartered in Kobe that specializes in remote medical support for intensive care unit (ICU) operations. The company addresses the critical shortage of intensivists in Japan by offering a remote consultation system called "RELIEVE," which provides 24/7 support from a team of experienced intensivists and certified intensive care nurses. This system enables non-specialized doctors to manage critically ill patients more effectively, alleviating the stress associated with high-stakes medical situations. In addition to tele-intensive care consultations, Vitaars also offers training for healthcare professionals in intensive and emergency care, enhancing their skills and improving patient outcomes. Through its innovative services, Vitaars ensures that patients receive essential intensive care regardless of their location or the time of day.
Novenine
Venture Round in 2019
Novenine, Inc. is a technology company based in Osaka, Japan, that specializes in oral health care consultation services and the distribution of oral health care products. Founded in 2018, the company focuses on the development and operation of innovative dental care solutions, including smart toothbrushes and a dental care clinic aimed at preventing serious dental diseases. Novenine offers specially designed toothbrushes and teleconsultation services with dental specialists, enabling patients to seek early assistance and take proactive measures for their oral health. Through its comprehensive approach, the company aims to enhance dental care and promote better health management in the community.
Koala Tech
Venture Round in 2019
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
iCare
Venture Round in 2019
iCare Co., Ltd., established in 2011 and headquartered in Tokyo, Japan, specializes in health management solutions. It operates a cloud-based platform that consolidates and securely stores employee health information, including check-up results, stress levels, work hours, and consultation records. iCare's platform is designed to alleviate administrative burdens from businesses, enabling them to better manage employee health and well-being. The company is recognized as the leading health and labor cloud solution provider in Japan, catering to both small and medium-sized enterprises and large corporations expanding globally.
Photo Electron Soul
Venture Round in 2019
Founded in Nagoya, Japan in 2015, Photo Electron Soul specializes in developing and managing photocathode electron beam systems. The company manufactures an electron beam generating apparatus using semiconductor photocathode technology, aiming to innovate fine observation and processing across various industries.
Academist
Series A in 2019
Founded in Tokyo, Japan in 2013, Academist operates a cloud-funding platform specializing in acquiring research funds. It enables researchers to raise funds for their projects by connecting them with a large community of supporters.
miup
Venture Round in 2018
miup, Inc. is a healthcare company founded in 2015 and based in Tokyo, Japan. It focuses on providing medical care services both in Asia and internationally, with an emphasis on preventive care and data collection in emerging markets. The company operates clinical testing centers and offers delivery-type medical examinations and telemedicine services. Additionally, miup develops laboratory information systems and customer management systems that utilize AI for screening and interview assistance, which enables medical professionals to deliver personalized care more efficiently. By leveraging vital data to improve diagnostic assistance and risk prediction accuracy, miup aims to create a comprehensive wellness ecosystem that enhances health management, diagnosis, and prevention for individuals globally.
Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.
Founded in 2006, QD Laser specializes in manufacturing quantum dot semiconductor lasers and wafers for various applications such as communications, industrial processing, and medical imaging. Its product portfolio includes picosecond lasers for precision machining, color-specific lasers for biological sciences, laser arrays for silicon optical circuits, and broadband gain chips for ophthalmic testing. Headquartered in Kawasaki, Japan, the company serves diverse industries including telecommunications, manufacturing, medicine, and consumer products.
Vitaars
Secondary Market in 2018
Vitaars, known as T-ICU Co., Ltd., is a Japanese company headquartered in Kobe that specializes in remote medical support for intensive care unit (ICU) operations. The company addresses the critical shortage of intensivists in Japan by offering a remote consultation system called "RELIEVE," which provides 24/7 support from a team of experienced intensivists and certified intensive care nurses. This system enables non-specialized doctors to manage critically ill patients more effectively, alleviating the stress associated with high-stakes medical situations. In addition to tele-intensive care consultations, Vitaars also offers training for healthcare professionals in intensive and emergency care, enhancing their skills and improving patient outcomes. Through its innovative services, Vitaars ensures that patients receive essential intensive care regardless of their location or the time of day.
Xenoma
Venture Round in 2018
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.
Integriculture
Seed Round in 2018
Integriculture develops cellular agriculture products including clean meat and clean foie gras, and offers scientific visual content production. Founded in 2015 and based in Tokyo, Japan, the company aims to enhance sustainability and food security by enabling scalable cell culture. Its patented general-purpose large-scale cell culture system can culture a wide range of cells without external growth factors, enabling affordable clean processed meat. This technology supports the production of safer, more sustainable alternatives to conventional meat and broader access to cellular agriculture solutions.
Lily MedTech
Series A in 2018
Lily MedTech Inc. is a medical device company based in Tokyo, Japan, founded in 2016. It specializes in the development and manufacture of innovative ultrasound diagnostic imaging equipment specifically designed for breast cancer detection. The company's flagship product is a ring echo device that utilizes a ring-type ultrasonic transducer to capture 3D images of the entire breast. This technology allows for a non-deforming examination process, which minimizes discomfort and reduces exposure to risks during diagnostic procedures. Lily MedTech's focus on enhancing breast ultrasound diagnostics aims to improve the overall experience for both patients and healthcare providers.
Photo Electron Soul
Venture Round in 2018
Founded in Nagoya, Japan in 2015, Photo Electron Soul specializes in developing and managing photocathode electron beam systems. The company manufactures an electron beam generating apparatus using semiconductor photocathode technology, aiming to innovate fine observation and processing across various industries.
iCare
Venture Round in 2018
iCare Co., Ltd., established in 2011 and headquartered in Tokyo, Japan, specializes in health management solutions. It operates a cloud-based platform that consolidates and securely stores employee health information, including check-up results, stress levels, work hours, and consultation records. iCare's platform is designed to alleviate administrative burdens from businesses, enabling them to better manage employee health and well-being. The company is recognized as the leading health and labor cloud solution provider in Japan, catering to both small and medium-sized enterprises and large corporations expanding globally.
Riverfield
Series B in 2017
Riverfield, Inc. is a Tokyo-based company founded in 2014, specializing in the development of surgical support robotic systems for the healthcare industry. The company's innovative technology integrates air pressure control mechanisms to facilitate delicate and precise movements, enhancing operability for medical professionals during surgical procedures. By focusing on creating user-friendly robotic solutions, Riverfield aims to significantly contribute to the advancement of medical practices and improve patient outcomes.
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.
Elephantech
Series A in 2017
Founded in Tokyo, Japan in 2014, Elephantech specializes in the manufacturing of electronic circuits. The company's innovative metal inkjet printing technology enables it to produce flexible printed circuit boards sustainably.
Myoridge
Seed Round in 2017
Myoridge Co. Ltd., established in 2016 and headquartered in Kyoto, Japan, specializes in developing a suspension culture system for scalable differentiation of pluripotent cells into desired cell types, notably cardiomyocytes. The company's innovative process employs a proprietary small-molecule compound, eliminating the need for proteins, thereby reducing production costs and ensuring lot-to-lot uniformity. Myoridge offers iPS cell-derived cardiomyocytes, cardiomyocyte fibers, and software for myocardial motion/fluorescence analysis, enabling advancements in regenerative medicine and drug discovery research.
CureApp, Inc. is a Tokyo-based digital health startup founded in 2014, specializing in the development of mobile applications aimed at treating various diseases. The company is recognized for its innovative approach to healthcare, particularly with its nicotine addiction treatment app launched in February 2015, which was developed in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp’s platform not only promotes clinical trials but also focuses on providing real-time, personalized guidance for lifestyle diseases through a cloud-based system that analyzes daily activity logs. This enables patients to manage their conditions more effectively, addressing health issues that are often overlooked by traditional medications and devices.
OryLab
Venture Round in 2016
OryLab is a Tokyo-based developer and manufacturer focused on communication technology and robotics. The company conducts research and development, as well as production and sales of hardware solutions that enable remote interaction. Its robots are small, remote-controlled devices designed to act as an alter-ego for users, capable of talking with others and moving limbs through an internet connection, with the aim of addressing loneliness. OryLab combines hardware innovation with commercial deployment of integrated communication and robotic technologies in its markets.
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin technology, which integrates wearable electronics into apparel. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and flexible devices that can seamlessly interface with the human body. The company's innovative clothing line incorporates highly sensitive motion sensors capable of monitoring movement, posture, breathing, and body temperature, while also being durable and machine washable. By collecting accurate data from these sensors, Xenoma aims to enhance healthcare through the integration of big data and IoT solutions, ultimately providing users with comfortable and functional wearable technology.
Riverfield
Venture Round in 2016
Riverfield, Inc. is a Tokyo-based company founded in 2014, specializing in the development of surgical support robotic systems for the healthcare industry. The company's innovative technology integrates air pressure control mechanisms to facilitate delicate and precise movements, enhancing operability for medical professionals during surgical procedures. By focusing on creating user-friendly robotic solutions, Riverfield aims to significantly contribute to the advancement of medical practices and improve patient outcomes.
Elephantech
Seed Round in 2016
Founded in Tokyo, Japan in 2014, Elephantech specializes in the manufacturing of electronic circuits. The company's innovative metal inkjet printing technology enables it to produce flexible printed circuit boards sustainably.
CureApp
Seed Round in 2015
CureApp, Inc. is a Tokyo-based digital health startup founded in 2014, specializing in the development of mobile applications aimed at treating various diseases. The company is recognized for its innovative approach to healthcare, particularly with its nicotine addiction treatment app launched in February 2015, which was developed in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp’s platform not only promotes clinical trials but also focuses on providing real-time, personalized guidance for lifestyle diseases through a cloud-based system that analyzes daily activity logs. This enables patients to manage their conditions more effectively, addressing health issues that are often overlooked by traditional medications and devices.